Journal Mobile Options
Table of Contents
Vol. 61, No. 1, 2012
Issue release date: August 2012

Effects of Medical Nutrition Therapy on Body Fat and Metabolic Syndrome Components in Premenopausal Overweight Women

Lim H. · Son J.-Y. · Choue R.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background/Aims: To evaluate the effects of medical nutrition therapy (MNT) on body composition and metabolic syndrome (MetS) components in premenopausal Korean women with a body mass index ≥23. Methods: Participants (n = 160) were classified into MetS (n = 44) or non-MetS (n = 116) groups based on the criteria proposed by the revised National Cholesterol Education Program-Adult Treatment Panel III and the International Diabetes Federation classification. Anthropometric and dietary assessments and blood analyses were performed for all participants prior to and following 12 weeks of MNT. Results: Following MNT, body fat decreased in both groups by roughly 11% (p < 0.001), and the number of participants meeting the criteria for MetS thus decreased from 44 to 19 (56.8%). Mean waist circumference (WC), blood pressure (BP), plasma triglyceride (TG) and blood glucose levels decreased in the MetS group (p < 0.001). Body fat reduction in the MetS group was correlated with changes in WC (r = 0.584), systolic BP (r = 0.451), diastolic BP (r = 0.429) and plasma TG (r = 0.488) levels after adjusting for covariates (p < 0.05). Conclusions: Body fat reduction and MetS component improvement was achieved by MNT in overweight women. Changes in MetS components appear to be related to body fat reduction. MNT should focus on body fat reduction when used as a primary prevention for MetS.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005;365:1415–1428.
  2. Hu G, Lindstrom J, Jousilahti P, Peltonen M, Sjoberg L, Kaaja R, Sundvall J, Tuomilehto J: The increasing prevalence of metabolic syndrome among Finnish men and women over a decade. J Clin Endocrinol Metab 2008;93:832–836.
  3. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003;163:427–436.
  4. McKeigue PM, Shah B, Marmot MG: Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382–386.
  5. Park HS, Oh SW, Cho SI, Choi WH, Kim YS: The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 2004;33:328–336.

    External Resources

  6. Chung HW, Kim DJ, Jin HD, Choi SH, Ahn CW, Cha BS, Lee HC, Huh KB: Prevalence of metabolic syndrome according to the new criteria for obesity. J Korean Diabet Assoc 2002;26:431–442.
  7. Kim MH, Kim MK, Choi BY, Shin YJ: Prevalence of the metabolic syndrome and its association with cardiovascular diseases in Korea. J Korean Med Sci 2004;19:195–201.
  8. Kim SW, Kim JY, Kim ES, Kim YI, Lee MS, Kim HH, Park JY, Hong SK, Lee KU: Prevalence of insulin resistance syndrome in subjects living in Jungup district, Korea. J Korean Diabet Assoc 1999;23:70–78.
  9. Lee CM, Huxley RR, Woodward M, Zimmet P, Shaw J, Cho NH, Kim HR, Viali S, Tominaga M, Vistisen D, Borch-Johnsen K, Colagiuri S: Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region. Metab Syndr Relat Disord 2008;6:37–46.

    External Resources

  10. Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW: Prevalence of the metabolic syndrome as defined by NCEP-ATP III among the urban Korean population. Korean J Med 2002;63:290–298.
  11. Park HS, Park CY, Oh SW, Yoo HJ: Prevalence of obesity and metabolic syndrome in Korean adults. Obes Rev 2008;9:104–107.
  12. Lee MH, Kim HC, Thomas GN, Ahn SV, Hur NW, Choi DP, Suh I: Familial concordance of metabolic syndrome in Korean population – Korean National Health and Nutrition Examination Survey 2005. Diabetes Res Clin Pract 2011;93:430–436.

    External Resources

  13. Ilanne-Parikka P, Eriksson JG, Lindstrom J, Peltonen M, Aunola S, Hamalainen H, Keinanen-Kiukaanniemi S, Laakso M, Valle TT, Lahtela J, Uusitupa M, Tuomilehto J: Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study. Diabetes Care 2008;31:805–807.

    External Resources

  14. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S: The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005;142:611–619.
  15. Goodpaster BH, Delany JP, Otto AD, Kuller L, Vockley J, South-Paul JE, Thomas SB, Brown J, McTigue K, Hames KC, Lang W, Jakicic JM: Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA 2010;304:1795–1802.
  16. Michael P: Impact and components of the Medicare MNT benefit. J Am Diet Assoc 2001;101:1140–1141.
  17. Troyer JL, McAuley WJ, McCutcheon ME: Cost-effectiveness of medical nutrition therapy and therapeutically designed meals for older adults with cardiovascular disease. J Am Diet Assoc 2010;110:1840–1851.

    External Resources

  18. WHO/IASO/IOTF: The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Melbourne, Health Communications, 2000.
  19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–2752.
  20. Alberti KG, Zimmet P, Shaw J: Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469–480.
  21. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB, Oh SJ, Park CY, Yoo HJ: Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75:72–80.
  22. Korean Society for the Study of Obesity (KSSO): Management of Metabolic syndrome. Seoul, Euihak munhwa, 2005.
  23. Harris JA, Benedict FG: A Biometric Study of Basal Metabolism in Man. Washington, Carnegie Institution, 1919.
  24. Case CC, Jones PH, Nelson K, O’Brian Smith E, Ballantyne CM: Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 2002;4:407–414.
  25. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D’Armiento M, D’Andrea F, Giugliano D: Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004;292:1440–1446.
  26. Yoo KD, Ko SH, Park JE, Ahn YB, Yim HW, Lee WC, Park YM: High serum ferritin levels are associated with metabolic risk factors in non-obese Korean young adults: Korean National Health and Nutrition Examination Survey (KNHANES) IV. Clin Endocrinol (Oxf) 2011, E-pub ahead of print.
  27. Kim HC, Kim DJ: Causes of different estimates of the prevalence of metabolic syndrome in Korea. Korean J Intern Med 2011;26:440–448.
  28. Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS: Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 2008;207:928–934.
  29. Zuo H, Shi Z, Hu X, Wu M, Guo Z, Hussain A: Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism 2009;58:1102–1108.
  30. Lee K, Lee J, Bae WK, Choi JK, Kim HJ, Cho B: Efficacy of low-calorie, partial meal replacement diet plans on weight and abdominal fat in obese subjects with metabolic syndrome: a double-blind, randomised controlled trial of two diet plans – one high in protein and one nutritionally balanced. Int J Clin Pract 2009;63:195–201.
  31. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D’Agostino RB Sr, O’Donnell CJ: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39–48.
  32. Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, Taylor HA: Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab 2010;95:5419–5426.
  33. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O’Donnel CJ, Fox CS: Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 2009;32:1068–1075.
  34. Kim S, Cho B, Lee H, Choi K, Hwang SS, Kim D, Kim K, Kwon H: Distribution of abdominal visceral and subcutaneous adipose tissue and metabolic syndrome in a Korean population. Diabetes Care 2011;34:504–506.

    External Resources

  35. Fappa E, Yannakoulia M, Pitsavos C, Skoumas I, Valourdou S, Stefanadis C: Lifestyle intervention in the management of metabolic syndrome: could we improve adherence issues? Nutrition 2008;24:286–291.

    External Resources

  36. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F: Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005;28:2823–2831.
  37. Meckling KA, Sherfey R: A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the Metabolic Syndrome in overweight and obese women. Appl Physiol Nutr Metab 2007;32:743–752.
  38. Shenoy SF, Poston WS, Reeves RS, Kazaks AG, Holt RR, Keen CL, Chen HJ, Haddock CK, Winters BL, Khoo CS, Foreyt JP: Weight loss in individuals with metabolic syndrome given DASH diet counseling when provided a low sodium vegetable juice: a randomized controlled trial. Nutr J 2010;9:8.

    External Resources

  39. Foreyt JP: The role of lifestyle modification in dysmetabolic syndrome management. Nestle Nutr Workshop Ser Clin Perform Programme 2006;11:197–205, discussion 205–206.

    External Resources

  40. Flechtner-Mors M, Boehm BO, Wittmann R, Thoma U, Ditschuneit HH: Enhanced weight loss with protein-enriched meal replacements in subjects with the metabolic syndrome. Diabetes Metab Res Rev 2010;26:393–405.
  41. Deurenberg-Yap M, Chew SK, Lin VF, Tan BY, van Staveren WA, Deurenberg P: Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore. Int J Obes Relat Metab Disord 2001;25:1554–1562.
  42. Park HS, Oh SW, Kang JH, Park YW, Kim YS, Choi WH: Prevalence and associated factors with metabolic syndrome in South Korea. J Korean Soc Study Obes 2003;12:1–14.
  43. Melanson KJ, Dell’Olio J, Carpenter MR, Angelopoulos TJ: Changes in multiple health outcomes at 12 and 24 weeks resulting from 12 weeks of exercise counseling with or without dietary counseling in obese adults. Nutrition 2004;20:849–856.

    External Resources

  44. Janssen I, Katzmarzyk PT, Ross R: Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004;79:379–384.
  45. Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, Stedman SW, Young DR: Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003;289:2083–2093.
  46. Shin CY, Yun KE, Park HS: Blood pressure has a greater impact on cardiovascular mortality than other components of metabolic syndrome in Koreans. Atherosclerosis 2009;205:614–619.
  47. Brandon LJ, Elliott-Lloyd MB: Walking, body composition, and blood pressure dose-response in African American and white women. Ethn Dis 2006;16:675–681.

    External Resources

  48. Cornelissen VA, Fagard RH: Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 2005;46:667–675.
  49. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D, Milas NC, Mattfeldt-Beman M, Belden L, Bragg C, Millstone M, Raczynski J, Brewer A, Singh B, Cohen J: Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001;134:1–11.
  50. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM: Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003;42:878–884.
  51. Delahanty LM, Sonnenberg LM, Hayden D, Nathan DM: Clinical and cost outcomes of medical nutrition therapy for hypercholesterolemia: a controlled trial. J Am Diet Assoc 2001;101:1012–1023.
  52. Lim HJ, Choi YM, Choue R: Dietary intervention with emphasis on folate intake reduces serum lipids but not plasma homocysteine levels in hyperlipidemic patients. Nutr Res 2008;28:767–774.
  53. Kasim-Karakas SE, Almario RU, Mueller WM, Peerson J: Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: effects of energy intake. Am J Clin Nutr 2000;71:1439–1447.
  54. Noakes M, Keogh JB, Foster PR, Clifton PM: Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clin Nutr 2005;81:1298–1306.
  55. Industry of Health and Welfare, Korea Health Industry Development Institute: In-Depth Analysis on the 3rd (2005) Korea Health and Nutrition Examination Survey – Nutrition Survey. Seoul, Industry of Health and Welfare, 2007.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50